Diplopia and Fluoroquinolones

Ophthalmology

Volumn 116, Issue 9, 2009, Pages 1814-1817

  Fraunfelder, Frederick W ^a   Fraunfelder, Frederick T ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; GATIFLOXACIN; LEVOFLOXACIN; MOXIFLOXACIN; NORFLOXACIN; OFLOXACIN; PROPACET; PROPACETAMOL; PYRIDOSTIGMINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SELDANE D; STEROID; TERFENADINE; TRIAMCINOLONE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; COMORBIDITY; DIPLOPIA; DRUG RECHALLENGE; DRUG SURVEILLANCE PROGRAM; EXTRAOCULAR MUSCLE; FATIGUE; FEMALE; FOOD AND DRUG ADMINISTRATION; HUMAN; KIDNEY CYST; MAJOR CLINICAL STUDY; MALE; MUSCLE WEAKNESS; PRIORITY JOURNAL; REGISTER; SYSTEMIC DISEASE; TENDINITIS; TREATMENT DURATION; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CHILD; DATABASES, FACTUAL; DIPLOPIA; FEMALE; FLUOROQUINOLONES; HUMANS; MALE; MIDDLE AGED; NUCLEIC ACID SYNTHESIS INHIBITORS; REGISTRIES; TENDINOPATHY; TIME FACTORS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION; WORLD HEALTH ORGANIZATION;

EID: 69249202316     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2009.06.027     Document Type: Article

References (17)

1. Owens Jr. R.C., and Ambrose P.G. Antimicrobial safety: focus on fluoroquinolones. Clin Infect Dis 41 suppl (2005) S144-S157
2. De Sarro A., and De Sarro G. Adverse reactions to fluoroquinolones: an overview on mechanistic aspects. Curr Med Chem 8 (2001) 371-384
3. 2006 Physicians' Desk Reference (PDR). 60th ed. (2006), Thomson PDR, Montvale, NJ 2991-2998
4. Edwards I.R., and Biriell C. Harmonisation in pharmacovigilance. Drug Saf 10 (1994) 93-102
5. Linder J.A., Huang E.S., Steinman M.A., et al. Fluoroquinolone prescribing in the United States: 1995 to 2002. Am J Med 118 (2005) 259-268
6. Moore B., Safani M., and Keesey J. Possible exacerbation of myasthenia gravis by ciprofloxacin. [letter]. Lancet 1 (1988) 882
7. Motolese E., d'Aniello B., and Addabbo G. Toxic optic neuropathy after administration of quinolone derivative. [in Italian]. Boll Ocul 69 (1990) 1011-1013
8. Winrow A.P., and Supramaniam G. Benign intracranial hypertension after ciprofloxacin administration. Arch Dis Child 65 (1990) 1165-1166
9. Cano Parra J., and Diaz-Llopis M. Drug induced uveitis. [in Spanish]. Arch Soc Esp Oftalmol 80 (2005) 137-149
10. Muzi F., Gravanta G., Tati E., and Tati G. Fluoroquinolones-induced tendinitis and tendon rupture in kidney transplant recipients: 2 cases and a review of the literature. Transplant Proc 39 (2007) 1673-1675
11. Zabraniecki L., Negrier I., Vergne P., et al. Fluoroquinolone induced tendinopathy: report of 6 cases. J Rheumatol 23 (1996) 516-520
12. Sendzik J., Shakibaei M., Schafer-Korting M., and Stahlmann R. Fluoroquinolones cause changes in extracellular matrix, signaling proteins, metalloproteinases and caspase-3 in cultured human tendon cells. Toxicology 212 (2005) 24-36
13. Corps A.N., Harrall R.L., Curry V.A., et al. Ciprofloxacin enhances the stimulation of matrix metalloproteinase 3 expression by interleukin-1beta in human tendon-derived cells: a potential mechanism of fluoroquinolone-induced tendinopathy. Arthritis Rheum 46 (2002) 3034-3040
14. Shakibaei M., and Stahlmann R. Ultrastructure of Achilles tendon from rats after treatment with fleroxacin. Arch Toxicol 75 (2001) 97-102
15. Pouzaud F., Bernard-Beaubois K., Thevenin M., et al. In vitro discrimination of fluoroquinolones toxicity of tendon cells: involvement of oxidative stress. J Pharmacol Exp Ther 308 (2004) 394-402
16. van der Linden P.D., van de Lei J., Nab H.W., et al. Achilles tendinitis associated with fluoroquinolones. Br J Clin Pharmacol 48 (1999) 433-437
17. Gabutti L., Stoller R., and Marti H.P. Fluoroquinolones as etiology of tendinopathy. [in German]. Ther Umsch 55 (1998) 558-561